NIH-funded research R15 grant

Dual-Mode Ultrasound and Near-Infrared Fluorescence Imaging with Metal-Doped Graphene Quantum Dots

Official title: Merging Sound and Light: Dual-Mode Ultrasound/NIR Fluorescence Imaging with Metal-Doped Graphene Quantum Dots

Funded at Texas Christian University · NIH-11291362 · Data updated 2026-11-12

Aimed at people who may need clearer, deeper imaging, this project tests a new dual-mode contrast agent that helps ultrasound and infrared fluorescence work together.

More Ultrasound research and trials

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionTexas Christian University
NIH-funded
Lab location1 site (Fort Worth, United States)
Project startAugust 18, 2026
Project endAugust 17, 2029
Funding year2026
Award (this year)$495,541
NIH project number1R15EB038729-01
Project IDNIH-11291362 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with conditions where ultrasound and fluorescence imaging could improve diagnostic accuracy.

Less likely to help

Patients with conditions where imaging does not rely on ultrasound or fluorescence, or where there is no need for contrast agents, may not benefit.

What this research studies

This project develops metal-doped graphene quantum dots that work as a single contrast agent for both ultrasound and near-infrared fluorescence imaging. The approach seeks to improve deep-tissue visualization while keeping costs and portability favorable. Researchers will synthesize the dots, test their imaging performance in animal models, and validate how well they provide combined ultrasound and fluorescence signals. The goal is to create a safer, more affordable option that could enhance diagnosis and guide treatment decisions.

Why it matters

Potential benefit: If successful, patients could benefit from clearer, deeper, and more affordable diagnostic imaging.

How similar studies have gone: Previous work shows that dual-mode imaging concepts can work in small animals, but the specific metal-doped graphene quantum dot platform is novel.

Where this research is happening

  • Texas Christian University
    Fort Worth, United States
    Active

Researchers

  • Principal investigator: Naumov, Anton — Texas Christian University
  • Study coordinator: Naumov, Anton

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.